WIN-Partners Co., Ltd. (TYO:3183)
1,563.00
+44.00 (2.90%)
Mar 14, 2025, 3:30 PM JST
WIN-Partners Revenue
WIN-Partners had revenue of 21.49B JPY in the quarter ending December 31, 2024, with 8.99% growth. This brings the company's revenue in the last twelve months to 82.61B, up 11.04% year-over-year. In the fiscal year ending March 31, 2024, WIN-Partners had annual revenue of 77.06B with 8.76% growth.
Revenue (ttm)
82.61B
Revenue Growth
+11.04%
P/S Ratio
0.52
Revenue / Employee
131.33M
Employees
629
Market Cap
43.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 77.06B | 6.21B | 8.76% |
Mar 31, 2023 | 70.85B | 4.46B | 6.72% |
Mar 31, 2022 | 66.39B | 4.27B | 6.87% |
Mar 31, 2021 | 62.12B | -2.41B | -3.74% |
Mar 31, 2020 | 64.54B | -5.24B | -7.51% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |